Searchable abstracts of presentations at key conferences in endocrinology

ea0091wf9 | Workshop F: Disorders of the parathyroid glands, calcium metabolism and bone | SFEEU2023

Primary hyperparathyroidism in pregnancy

Hirwa Kagabo , Patel Nishchil , Dimitropoulos Ioannis

A 30-year-old lady was initially seen in our clinic with a slight elevated corrected calcium with an elevated parathyroid hormone in March 2021. The elevated calcium [2.58mmol/l(NR: 2.10-2.55)] was first noted in 2018 when she had investigations for easy bruising, fatigue, breathlessness, and weight loss. The symptoms settled on their own and her calcium levels were monitored routinely. She was referred to our clinic when the corrected calcium had increased to 2.69mmol/lwith a...

ea0091wh7 | Workshop H: Miscellaneous endocrine and metabolic disorders | SFEEU2023

Erdheim Chester disease as a cause of Diabetes Insipidus

Nyi Nyi Htet Soe , Hirwa Kagabo , Smith Jamie

Case Summary: A 53-year-old lady who was normally fit and well, presented with a 3 months history of polydipsia and excessive polyuria up to 13 litres a day. A water deprivation test confirmed a cranial diabetes insipidus, and she was started on desmopressin. Apart from hypothyroidism that was well controlled with levothyroxine replacement, the rest of her pituitary profile was unremarkable for a lady of her age. The rest of her investigations showed persistent increased infla...

ea0075m07 | Metabolic Bone | EYES2021

Familial hypocalciuric hypercalcaemia or primary hyperparathyroidism?

Hirwa Kagabo , Patel Nishchil , Biaye Abraham , Flanagan Daniel

Background: Primary hyperparathyroidism is the commonest cause of hypercalcemia. Current guidelines advise to rule out familial hypocalciuric hypercalcemia (FHH) when evaluating hypercalcemia. It is widely considered that FHH is associated with low urine calcium creatinine clearance ratio (CCCR). However, low CCCR can also occur in Primary hyperparathyroidism.Case: A 30 years lady presented with hypercalcemia and high parathyroid hormone (PTH). She had a...

ea0075p06 | Pituitary and neuroendocrinology | EYES2021

Discrepancy between short synacthen test (sst) and insulin stimulation test (ist)

Hirwa Kagabo , Patel Nishchil , Biaye Abraham , Flanagan Daniel

Background: Hypothalamus pituitary adrenal axis (HPA) dysfunction is associated with serious morbidity and mortality. Its symptoms can be non-specific. Objective diagnosis depends on clinical suspicion and confirmed on assessment of early morning cortisol or dynamic assessment of cortisol secretion. The cosyntropin or short synacthen test (SST) has emerged as the most common test to assess the HPA. The insulin stimulation test (IST) is the traditional ‘gold standard’...

ea0075t09 | Thyroid | EYES2021

Unmasking the pseudo-myaesthenic imposter

Patel Nishchil , Hirwa Kagabo , Biaye Abraham , Flanagan Daniel

Background: Myasthenia gravis and thyroid disease can sometimes create diagnostic confusion because the two may have similar clinical features and may also co-exist in the same individual.Case: A 68 years male, was seen in the Neurology clinic with drooping of his left eyelid, first noticed 8 months prior, worse in the evenings. There were no other complaints. He had history of type2 diabetes, and Graves’ disease. On examination, he appeared to have...

ea0086p346 | Neuroendocrinology and Pituitary | SFEBES2022

Immune checkpoint inhibitor related hypothalamus pituitary adrenal axis dysfunction: A retrospective study in Derriford Hospital

Gardner Gemma , Hirwa Kagabo , Pyone Khine May , Patel Nishchil , Edeghere Simon , Flanagan Daniel

Background: Newer biological drugs such as immune checkpoint inhibitors (ICI) have recently revolutionized cancer therapy. However, hypophysitis and adrenalitis are recognized side-effects of these new therapies. Hypothalamus pituitary adrenal (HPA) axis dysfunction is associated with serious morbidity and mortality. This study aimed to monitor whether the ICI related HPA axis dysfunction recovers.Materials and Methods: We have conducted a retrospective ...